clodronate disodium

DRUG3 trials

Sponsors

NCIC Clinical Trials Group, SWOG Cancer Research Network

Conditions

Breast CancerPainProstate CancerQuality of Life

Phase 3

Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer

CompletedNCT00003232

NCIC Clinical Trials GroupPain, Prostate Cancer, Quality of Life

Start: 1997-11-24End: 2009-02-10Updated: 2020-04-03

S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.

CompletedNCT00127205

SWOG Cancer Research NetworkBreast Cancer

Start: 2005-07-31End: 2021-03-29Updated: 2021-07-02

Unknown Phase

S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307

WithdrawnNCT00873808

SWOG Cancer Research NetworkBreast Cancer

Start: 2008-10-31End: 2010-02-28Updated: 2013-04-10

Related Papers

Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307).

2020-09-1523 citations

Abstract P2-18-02: Fractures in women with breast cancer receiving high-dose bisphosphonates to prevent breast cancer metastases as part of the SWOG S0307 trial (ClinicalTrials.gov Identifier: NCT00127205)

Cancer Research2020-02-15

Factors associated with osteonecrosis of the jaw in women with breast cancer receiving high-dose bisphosphonates to prevent breast cancer metastases as part of the SWOG 0307 trial.

Journal of Clinical Oncology2019-05-201 citations

Phase III trial of bisphosphonates as adjuvant therapy in primary breast cancer: SWOG/Alliance/ECOG-ACRIN/NCIC Clinical Trials Group/NRG Oncology study S0307.

Journal of Clinical Oncology2015-05-2023 citations

SWOG S0307 phase III trial of bisphosphonates as adjuvant therapy in primary breast cancer: Comparison of toxicities and patient-stated preference for oral versus intravenous delivery.

Journal of Clinical Oncology2014-05-2014 citations